The Articles of the Directive:
It increased the costs of doing clinical trials in the EU, and a reduction in the number of such trials followed its implementation,2 especially of academic-led studies, and ones looking at new uses for old drugs.3 Germany derogated from the directive.4 It is due to be replaced by the EU Clinical Trials Regulation in 2016.5 The changes are due to come into effect in the second half of 2019.6
https://eur-lex.europa.eu/eli/reg/2014/536/oj/eng https://eur-lex.europa.eu/eli/reg/2014/536/oj/eng ↩
The New EU Clinical Trials Regulation: The Good, the Bad, the Ugly http://vertassets.blob.core.windows.net/download/a78320af/a78320af-1b65-4bbe-b603-bb0540285015/synhcr_eu_ct_regulation.pdf ↩
A Dalgleish (8 October 2016). "We can now revive clinical trials killed by the EU". The Daily Telegraph. London. p. 21.print and online https://www.telegraph.co.uk/news/2016/10/07/brexit-means-we-can-revive-clinical-trials-killed-by-the-eu/ ↩
"European Medicines Agency - Clinical trials - Clinical Trial Regulation". ema.europa.eu. Archived from the original on 15 March 2018. https://web.archive.org/web/20180315003521/http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000629.jsp&mid=WC0b01ac05808768df ↩